节点文献
法舒地尔在动脉瘤破裂患者中应用的危险性评价
Fasudil in Patients with Aneurysm Rupture Risk Assessment Applications
【摘要】 目的:观察盐酸法舒地尔治疗动脉瘤破裂后蛛网膜下腔出血(SAH)所致脑血管痉挛的再出血的危险性评价。方法:回顾性分析我院2005~2009年的80例动脉瘤患者,根据在手术或栓塞治疗前是否使用盐酸法舒地尔治疗动脉癌破裂蛛网膜下腔出血所致脑血管痉挛分成2组,比较2组患者再次出血的危险性。结果:第Ⅰ组中共发生动脉瘤再破裂出血4例,第Ⅱ组中共发生动脉瘤再破裂出血5例。结论:盐酸法舒地尔治疗动脉瘤破裂后蛛网膜下腔出血时没有增加患者再出血的风险。
【Abstract】 Objective:To analyze the possibility of rerupture of fasudil hydrochloride on aneurysmal subarachnoid hemorrhage in patients with a ruptured cerebral aneurysm.Methods:80 cases of aneurysm from 2005 to 2009 in hospital were analyzed retrospectively. there were divided into two groups according whether fasudil hydrochloride were used.the data of rerupture were recorded.Results: There were 4 cases of rerupture in first group,5 cases of rerupture in second group.Conclusion:Hydrochloric acid fasudil treatment after aneurysmal rupture in patients with subarachnoid hemorrhage did not increase the risk of rebleeding.
- 【文献出处】 中国医药导刊 ,Chinese Journal of Medicinal Guide , 编辑部邮箱 ,2011年10期
- 【分类号】R743.34
- 【下载频次】1